57 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
8
Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A.
Selcia
1
Thioxylated cyclosporin A for studying protein-drug interactions.
Technical University Dresden
14
Design and synthesis of peptide-based macrocyclic cyclophilin inhibitors.
AstraZeneca
1
From chemical tools to clinical medicines: nonimmunosuppressive cyclophilin inhibitors derived from the cyclosporin and sanglifehrin scaffolds.
Novartis Institutes For Biomedical Research
14
Potent nonimmunosuppressive cyclophilin inhibitors with improved pharmaceutical properties and decreased transporter inhibition.
Novartis Institutes For Biomedical Research
9
Anti-inflammatory effects of extracellular cyclosporins are exclusively mediated by CD147.
Max Planck Research Unit For Enzymology of Protein Folding
20
Synthesis and biological evaluation of [D-lysine]8cyclosporin A analogs as potential anti-HCV agents.
Scynexis
1
Simultaneous identification of multiple receptors of natural product using an optimized cDNA phage display cloning.
Chinese Academy of Sciences
6
Synthesis and neurotrophic activity of nonimmunosuppressant cyclosporin A derivatives.
Guilford Pharmaceuticals
12
Structure-activity studies of ground- and transition-state analogue inhibitors of cyclophilin.
Southern Methodist University
32
Design of a Gag pentapeptide analogue that binds human cyclophilin A more efficiently than the entire capsid protein: new insights for the development of novel anti-HIV-1 drugs.
Departement D'Ingenierie Et D'Etudes Des Proteines
19
Synthesis of non-immunosuppressive cyclophilin-Binding cyclosporin A derivatives as potential anti-HIV-1 drugs.
Centre De Recherche De Paris
2
Oligopeptide cyclophilin inhibitors: a reassessment.
Max Planck Research Unit For Enzymology of Protein Folding
3
Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent.
Southern Research Institute
2
Facile synthesis of a fluorescent cyclosporin a analogue to study cyclophilin 40 and cyclophilin 18 ligands.
TBA
2
SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro.
Scynexis
6
Augmented photoswitching modulates immune signaling.
Max Planck Research Unit For Enzymology of Protein Folding
24
Discovering potent small molecule inhibitors of cyclophilin A using de novo drug design approach.
East China University of Science and Technology
29
Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
Peking University
19
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers.
Revolution Medicines
8
Insights into tumor-derived exosome inhibition in cancer therapy.
Nanjing University of Chinese Medicine
20
Optimization of Cyclophilin B-Targeted Tri-vector Inhibitors for Novel MASH Treatments.
University of Edinburgh
10
Discovery of Novel Oxazolo[4,3-f]purine Derivatives as Antitumor Agents through PPIA Interaction.
Henan Normal University
11
Ringing medicinal chemistry: The importance of 3-membered rings in drug discovery.
Monash University (Malaysia Campus)
9
Toward Dual Targeting of Catalytic and Gatekeeper Pockets in Cyclophilins Using a Macrocyclic Scaffold.
Technical University Darmstadt
5
Neuroprotective Effect of 2-(Benzyloxy)arylureas Is Not Related to CypD Inhibition nor Suppression of mPTP Opening.
University of Hradec Kralove
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.
Johann Wolfgang Goethe University
6
Drug discovery and optimization based on the co-crystal structure of natural product with target.
Anhui Medical University
31
Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds.
University of Michigan
5
Interplay among Conformation, Intramolecular Hydrogen Bonds, and Chameleonicity in the Membrane Permeability and Cyclophilin A Binding of Macrocyclic Peptide Cyclosporin O Derivatives.
Gwangju Institute of Science and Technology (Gist)
23
Structure-based design, synthesis, and biological evaluation of novel inhibitors of human cyclophilin A.
University of Montpellier
3
Design, Optimization, and Structural Characterization of an Apoptosis-Inducing Factor Peptide Targeting Human Cyclophilin A to Inhibit Apoptosis Inducing Factor-Mediated Cell Death.
University of Campania "L. Vanvitelli
27
Synthesis and biological evaluation of non-peptidic cyclophilin ligands.
Guilford Pharmaceuticals
1
SAR study of bisamides as cyclophilin a inhibitors for the development of host-targeting therapy for hepatitis C virus infection.
Chonnam National University
22
Molecular docking and 3D-QSAR studies on gag peptide analogue inhibitors interacting with human cyclophilin A.
Chinese Academy of Sciences
37
From Pyrazolones to Azaindoles: Evolution of Active-Site SHP2 Inhibitors Based on Scaffold Hopping and Bioisosteric Replacement.
Leibniz-Forschungsinstitut F�R Molekulare Pharmakologie (Fmp)
1
Molecular design, synthesis, and biological evaluation of bisamide derivatives as cyclophilin A inhibitors for HCV treatment.
Chonnam National University
3
Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections.
Chonnam National University
22
Identification, synthesis and pharmacological evaluation of novel anti-EV71 agents via cyclophilin A inhibition.
East China University of Science and Technology
3
Improved binding affinity for cyclophilin A by a cyclosporin derivative singly modified at its effector domain.
Sandoz Pharma
4
The role of water molecules in the structure-based design of (5-hydroxynorvaline)-2-cyclosporin: synthesis, biological activity, and crystallographic analysis with cyclophilin A.
Sandoz Pharma
23
Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle.
Gilead Sciences
19
BRD4 inhibitor as well as a preparative method and use thereof
Hinova Pharmaceuticals
14
Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives.
Quaid-I-Azam University
14
Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.
Cardiff University